[ad_1] Citron Research’s Andrew left reiterated his bet against the Canadian cannabis industry Wendesday, telling CNBC that he’s short Canopy Growth and Cronos Group in addition to his already disclosed wager against …
Read More »Cronos sales tripled in the final quarter after Canada's legalization of marijuana
[ad_1] Driven by recreational marijuana sales in Canada, Cronos Group Inc.'s sales tripled in the past quarter, as the weed grower fell, according to its quarterly published results Tuesday. Actions of Cronos …
Read More »Cronos perd de la valeur malgré la flambée des revenus, réservoirs d'actions
[ad_1] Les actions de Cronos Group Inc. (CRON) ont chuté de 8% peu de temps après l’ouverture du marché le mardi 13 novembre, après que la société productrice de cannabis eut enregistré …
Read More »Cronos Loses Value as Revenue Triples and Shares Fall
[ad_1] Shares of Cronos Group Inc. CRON, -1.17% The Toronto-based cannabis company reported a third-quarter loss, but revenues nearly tripled. The net loss was C $ 7.04 million, or 4 cents per …
Read More »Why did Tilray Inc.'s stock go up while Canopy Growth and Cronos Group sank today – The Motley Fool
[ad_1] What happened Actions of Tilray Inc. (NASDAQ: TLRY) were up 13.9%, while Canopy growth (NYSE: CGC) was down 11.6% and Cronos Group (NASDAQ: CRON) slipped 10.3% at 15:05 EDT Thursday. Tilray …
Read More »